Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXLANSOPRAZOLE Cause Pericardial effusion? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Pericardial effusion have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.0% of all adverse event reports for DEXLANSOPRAZOLE.

5
Reports of Pericardial effusion with DEXLANSOPRAZOLE
0.0%
of all DEXLANSOPRAZOLE reports
3
Deaths
1
Hospitalizations

How Dangerous Is Pericardial effusion From DEXLANSOPRAZOLE?

Of the 5 reports, 3 (60.0%) resulted in death, 1 (20.0%) required hospitalization.

Is Pericardial effusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does DEXLANSOPRAZOLE Cause?

Chronic kidney disease (15,973) Acute kidney injury (7,599) Renal failure (6,618) End stage renal disease (4,800) Renal injury (4,320) Tubulointerstitial nephritis (2,177) Death (1,417) Rebound acid hypersecretion (1,160) Gastrooesophageal reflux disease (1,013) Drug ineffective (859)

What Other Drugs Cause Pericardial effusion?

TREPROSTINIL (584) IBRUTINIB (467) CYCLOPHOSPHAMIDE (458) NIVOLUMAB (454) METHOTREXATE (412) MACITENTAN (407) DASATINIB (388) ADALIMUMAB (374) AMBRISENTAN (371) PEMBROLIZUMAB (362)

Which DEXLANSOPRAZOLE Alternatives Have Lower Pericardial effusion Risk?

DEXLANSOPRAZOLE vs DEXMEDETOMIDINE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXPANTHENOL DEXLANSOPRAZOLE vs DEXRAZOXANE

Related Pages

DEXLANSOPRAZOLE Full Profile All Pericardial effusion Reports All Drugs Causing Pericardial effusion DEXLANSOPRAZOLE Demographics